News
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...
2h
Zacks.com on MSNWill Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
4h
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
When we feed the body correctly, we can influence the same systems that drugs like Mounjaro target - helping regulate ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results